Rifampicin Resistance Pattern in Mycobacterium Tuberculosis Isolated from Patients Referred to Tehran TB Center

Message:
Article Type:
Research/Original Article (دارای رتبه معتبر)
Abstract:
Background and Aim

Multidrug- resistant (MDR) tuberculosis (TB) is caused by a strain of Mycobacterium tuberculosis (MTB) that was at least resistant to isoniazid (INH) and rifampicin (RIF). World Health Organization reported 399,000-501,000 cases of RIF resistance and they reported this case without knowing about this situation in Tehran. So, it is an important concern.

Methods

Descriptive method and research was done on 1000 clinical samples of people suspected of tuberculosis. All the samples were studied in the TB center of the province for microscopic examination and culture. Using the ratio method, the drug sensitivity test to the first- line anti- tuberculosis drug was performed for positive MTB cultures on Löwenstein- Jensen (LJ) culture medium. All isolates resistant and sensitive to RIF were identified by GeneXpert and the prevalence of resistance in the samples was determined and its actual level in the community was estimated. Then, using SPSS software, the level of resistance and factors affecting it were checked.

Results

According to theprevalence in these samples in this research, out of 440 positive samples, 3 positive samples, or 0.07% were resistant.

Conclusion

It seems that resistance to rifampin is not a big problem and is not a cause for concern. As a result, the prevalence of drug resistance in this study area was relatively low. Our suggestion is to conduct more studies in different regions of this country to evaluate the efficiency of GeneXpert and whether it can be useful and effective in Iran.

Language:
Persian
Published:
Journal of Research In Medical Sciences, Volume:47 Issue: 2, 2023
Pages:
98 to 105
magiran.com/p2612689  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!